RecruitingACTRN12616000194460

Hominax for improving sperm health

A pre and post study of the effect and safety of Hominax to improve sperm health


Sponsor

Max Biocare Pty Ltd

Enrollment

62 participants

Start Date

Dec 20, 2016

Study Type

Interventional

Conditions

Summary

This is a clinical trial examining the effectiveness of a vitamin supplement, Hominax, in improving sperm health. We are testing whether Hominax can improve sperm health. It is possible that Hominax can help prevent damage to sperm. Men will be allocated to receive either Hominax for 24 weeks. Sperm samples will be tested to look for a difference in sperm health between the pre- and post-treatment.


Eligibility

Sex: MalesMin Age: 20 YearssMax Age: 60 Yearss

Plain Language Summary

Simplified for easier understanding

This study tests whether a vitamin supplement called Hominax can improve sperm health in men with low or poor-quality sperm. Men with below-average sperm concentration, poor movement, or abnormal sperm shape are eligible. Participants take the supplement for 24 weeks, and sperm samples are compared before and after treatment. You may be eligible if: - You are a male between 20 and 60 years old - You have sperm results showing low concentration, poor movement, or abnormal shape (confirmed by two tests) - Your semen sample otherwise looks normal - You are willing to stop taking other vitamin or supplement products for the study duration - You can swallow capsules and are fluent in English You may NOT be eligible if: - Your infertility has a known cause (e.g. infection, varicocele, anti-sperm antibodies) - You smoke more than a pack of cigarettes per week - You drink more than 2 standard drinks per day on average - You have a bleeding disorder, HIV, hepatitis, thyroid disease, or seizure disorder - You have diabetes requiring insulin - You are already taking medications known to affect fertility Talk to your doctor about whether this trial might be right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

Hominax is a TGA-listed nutraceutical containing 15 micronutrients. Each capsule contains the following: L-carnitine 170.5mg, Acetyl-L-carnitine 84.10mg, Zinc 12.5mg, Ascorbic acid 60mg, Green tea (

Hominax is a TGA-listed nutraceutical containing 15 micronutrients. Each capsule contains the following: L-carnitine 170.5mg, Acetyl-L-carnitine 84.10mg, Zinc 12.5mg, Ascorbic acid 60mg, Green tea (Camellia sinensis) 600mg, Panax ginseng root dry 500mg, Vitamin E 50IU, Lycopene 3mg, Selenium 35mg, Ubidecarenone 25mg, Vitis vinifera (grape) seed dry 600mg, Cysteine 3.4mg, Pyridoxine 2.1mg, Cyanocobalamin 5mg, Folic acid 200mg. Dose administered will be 2 capsules by mouth, daily for 24 weeks. Compliance will be monitored by drug tablet return at 16 and 24 weeks (end of treatment).


Locations(1)

NSW,QLD, Australia

View Full Details on ANZCTR

For the most up-to-date information, visit the official listing.

Visit

ACTRN12616000194460